Globus Medical Q4 sales $250M (+7.1% YoY); FY21 sales $958.1M (+21.4%); guides FY22 sales $1.025B

GLOBUS MEDICAL INC

2021-FY EPS reported $1.44 revenue$958,102,000

Q4 GAAP diluted EPS $0.14, non-GAAP $0.49; GAAP net income $15.1M down 71.5% due to IPR&D acquisition
Full-year GAAP EPS $1.44, non-GAAP EPS $2.04; adjusted EBITDA $331.4M (34.6% of sales)
Enabling Technology revenue Q4 $25M, FY $81M (+100% YoY); US Spine +18%, International +12%
FY 2022 guidance: net sales $1.025B, non-GAAP diluted EPS $2.10; company remains debt-free
Free cash flow for FY 2021 was $219.4M

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.